EUCAST aims to review breakpoints for carbapenems, alone and in combination with inhibitors. Anyone with data to support a breakpoint process are invited to highlight and submit relevant evidence. At the end of the EUCAST process, we will invite colleagues to participate in the consultation process…
Get to know moreEUCAST has so far not defined breakpoints for C. auris, due to the lack of clinical outcome data and the high degree of clonality of this species. Thus, there is currently insufficient evidence to set breakpoints, but EUCAST are aware of other provisional cut-offs which are being used elsewhere, and…
Get to know morePublications by EUCAST in peer-reviewed journals 2025 2024 2023 2022 2021 2020 Archive Aminoglycoside breakpoints – the EUCAST approach and what this means for the clinician. C. Giske et al., Clin. Microbiol. Inf. 2025. Go to publication Rationale for contemporary antimicrobial treatment of…
Get to know moreInformation for pharmaceutical companies intending to bring new antimicrobial drugs to EUCAST for breakpoints The development of clinical breakpoints for new agents requires agreement and acceptance of the data generated in support of decisions on clinical breakpoints, wild type MIC distributions,…
Get to know moreEUCAST SOPs SOP 1.5 Setting breakpoints for new antimicrobial agents (9 May, 2025) SOP 2.5 Harmonising breakpoints for existing antimicrobial agents (12 May, 2025) SOP 3.4 Review and revision of breakpoints (6 May, 2025) SOP 4.7 EUCAST Committees and subcommittees (12 May, 2025) SOP 5.4 EUCAST and…
Get to know moreProposed revision of breakpoints for trimethoprim-sulfamethoxazole and trimethoprim. Public consultation 2025-05-07 - 2025-06-18. As a final result of each consultation, the comments obtained and the EUCAST Steering Committee rersponses are made public on the website. These are public comments and…
Get to know moreChairs: Alasdair MacGowan (Bristol, United Kingdom), Marlene Amara (Versailles, France) EUCAST update, Sören G. Gatermann (Bochum, Germany) Setting clinical breakpoints, assessing evidence, Anouk Muller (The Hague, Netherlands) Benzylpenicillin susceptibility testing of S. pneumoniae by disk…
Get to know moreCalibration and validation graphs related to breakpoint table v 11.0 (2021) updated 1 July, 2021.New for 2021, apart from introducing revised and new breakpoints for relevant agents and species,are graphs for Achromobacterxylosoxidans , Bacillus spp., Cefiderocol,Ceftolozane-tazobactam for H.…
Get to know moreRAST FAQ Inoculation of agar plates 1. Which is the easiest way to transfer blood from the positive blood culture bottle to the agar plate? Blood can be transferred to the agar plate either by a pipette (after first having transferred blood to an empty tube) or by applying drops on the plate from…
Get to know moreIdentifying the MIC wild type distribution and its delineation of species targeted for receiving antimicrobial agent breakpoints is an important first step for determining clinical breakpoints. Having the main responsibility in EUCAST for characterizing the wild-type distributions and the setting of…
Get to know more